Thursday, March 13, 2008
7:00 AM-8:00 AM |
| TA1 |
Obstetric Ultrasound: How to Keep It Safe?
Jacques Abramowicz, MD
Following this session, participants will be able to discuss the bioeffects of ultrasound, assess how changing scanner controls alters output, and identify ways to prevent undesired results. |
TA2 |
Fetal Echo in Aneuploidy SOLD OUT
Greggory DeVore, MD
The purpose of this session is to review the use of fetal echocardiography to detect fetuses with aneuploidy (trisomies 13, 18, and 21) during the second-trimester genetic sonogram. |
| TA3 |
Update on the Sonographic Early Detection of Ovarian Cancer
Arthur Fleischer, MD
Following this session, participants will be able to describe the data on studies concerning the efficiency of using sonography as a means for early detection of ovarian cancer and to identify the potentials and limitations of conventional and newer sonographic techniques for early detection of ovarian cancer. |
| TA4 |
Coding in Obstetric Ultrasound
Andrew Helfgott, MD
Following this session, participants will have a clearer understanding of coding for obstetric ultrasound and have a working knowledge of Current Procedural Terminology coding for obstetric ultrasound. |
TA5 |
Multiple Cesareans and Accreta: An Imaging and Management Challenge SOLD OUT
Thomas Moore, MD
At the conclusion of this session, participants will be able to understand the risk factors for placenta accreta, explain the range of morbidity with diagnosed or undiagnosed delivery of placenta accreta, describe the findings on ultrasound that have the highest sensitivity in predicting invasive placentation, describe the advantages and disadvantages of gadolinium in magnetic resonance imaging (MRI) of suspected placenta accreta, and describe the findings on MRI that have the highest sensitivity in predicting invasive placentation. |
TA6 |
Venous Reflux: Ultrasound Diagnosis and Treatment SOLD OUT
Leslie Scoutt, MD
Following this session, participants will be able to describe the superficial venous anatomy of the lower extremity; assess the lower extremity veins for reflux using Doppler ultrasound, and discuss the nonsurgical options for treatment of lower extremity varicose veins. |
TA7 |
The Athlete's Groin SOLD OUT
Marnix van Holsbeeck, MD
Following this session, participants will be able to discriminate causes of groin pain using ultrasound. |
| TA8 |
Consumer-Directed Health Care: Creating a Practice That Results in Patient Loyalty and Referrals
Robert Wolfson, MD, PhD
Consumer-directed health care continues to gain momentum. Health care is now about the experience. Participants will learn about the experience that patients seek and specific actions to take to ensure consistently satisfied patients and referring physicians. |
Thursday, March 13, 2008
11:45 AM-12:45 PM |
| TP1 |
Transesophageal Echo and Transthoracic Echo Use in Resuscitation
Michael Blaivas, MD
Following this session, participants should be able to discuss transesophageal echo (TEE) use in resuscitation, pitfalls common to transthoracic echo (TTE) and TEE, and common TTE/TEE findings in resuscitation. |
TP2 |
Postabortion and Postpartum Ultrasound SOLD OUT
Douglas Brown, MD
Following this session, participants will be able to describe the most useful sonographic features for identifying retained products of conception and discuss features unique to the post-cesarean delivery patient. |
| TP3 |
Thyroid Fine-Needle Aspiration: Why, When, and How?
Mark Lockhart, MD
After this session, participants will be able to understand the indications and clinical settings that lead to thyroid fine-needle aspiration (FNA). This session will enable them to access FNA techniques. |
TP4 |
Basic Screening for Congenital Heart Disease in Clinical Practice SOLD OUT
Mark Sklansky, MD
Following this session, participants will be able to identify the major problems with current screening methods for fetal heart disease. |
TP5 |
First-Trimester, Integrated, Sequential, and Contingent Risk Assessment for Down Syndrome: What Does It Mean? SOLD OUT
Steven Warsof, MD
Following this session, participants will be able to counsel patients appropriately through the maze of new first-trimester risk assessment options for Down syndrome. |
Friday, March 14, 2008
6:45 AM-7:45 AM |
| FA1 |
Controversies in Polycystic Ovary Syndrome: Diagnosis by Ultrasound
Misty Blanchette Porter, MD
Following this session, participants will be able to discuss the criteria for establishing the diagnosis of polycystic ovary syndrome (PCOS), discuss the role of pelvic ultrasound in establishing the diagnosis of PCOS, and review the indications for endometrial biopsy in patients with a thickened endometrial echo. |
FA2 |
Updates in Neonatal Neurosonology SOLD OUT
Dorothy Bulas, MD
Following this session, participants will be able to describe advanced sonographic techniques that are useful in imaging the neonatal brain, including the use of the transmastoid view and Doppler sonography. |
FA3 |
Is It Real or Is It an Artifact? SOLD OUT
Peter L. Cooperberg, MD, CM, FRCP(C)
After this session, participants will learn to appreciate how the physical principles of ultrasound can cause echoes to appear on the image that do not necessarily reflect the actual position or intensity of the actual interface in the body. Participants will then be able to avoid misdiagnosing abnormalities that are actually artifacts and avoid missing abnormalities that look like artifacts. |
FA4 |
Color Flow Doppler Ultrasound of the Fetal Heart SOLD OUT
Lisa Hornberger, MD
Following this session, participants will be able to understand the role of color flow Doppler in the evaluation of structural and functional fetal cardiovascular disease and in cardiac screening. |
| FA5 |
Ultrasound and Magnetic Resonance Imaging of Central Nervous System Anomalies
Deborah Levine, MD
Following this session, participants will be able to describe the types of central nervous system anomalies for which magnetic resonance imaging adds additional information beyond that available with ultrasound. |
| FA6 |
Vascular Protocols and Interpretation Criteria
Laurence Needleman, MD
Following this session, participants will be able to describe the necessary components to document and interpret carotid, lower extremity venous, upper extremity venous, arterial, and renal arterial duplex scans. |
Friday, March 14, 2008
12:15 PM-1:15 PM |
| FP1 |
Microbubble Contrast Agents and Their Clinical Use
Peter Burns, PhD
After this session, participants will be able to discuss the use of microbubble ultrasound contrast agents for clinical applications. |
FP2 |
Early Pregnancies of Unknown Location: An Increasing Trend SOLD OUT
Steven Goldstein, MD
Following this session, participants will be able to identify the widening gap between biochemical and sonographic detection of early pregnancies and the clinical problems this presents relative to normal early pregnancies versus failed pregnancies. Participants will also learn about a new entity, pregnancy of unknown location, as a new wrinkle in the old "rule out ectopic" procedure. |
FP3 |
Sonography of Inguinal Hernias SOLD OUT
David Jamadar, MBBS, FRCS, FRCR
Following this session, participants will be able to identify the sonographic anatomy of the inguinal region, allowing identification and diagnosis of inguinal hernias. |
FP4 |
Cardiac Abnormalities Seen in the 4-Chamber Heart SOLD OUT
John McGahan, MD
Following this session, participants will be able to identify major fetal cardiac defects, be aware of the pitfalls in outflow tract views, and understand newer views such as 5 short-axis views. |
| FP5 |
The Basic Fetal Cardiac Examination
Lami Yeo, MD
Following this session, participants will be able to understand and assess the fetal heart through a basic fetal cardiac examination. |
Saturday, March 15, 2008
7:00 AM-8:00 AM |
SA1 |
Three- and 4-Dimensional Cardiac Imaging SOLD OUT
Alfred Abuhamad, MD
This session will describe 3-dimensional (3D) and 4D ultrasound of the fetal heart and present future developments within 3D and 4D ultrasound. |
SA2 |
Ultrasound of the Pediatric Spine SOLD OUT
Michael DiPietro, MD
After this session, participants will understand clinical indications, techniques, and limitations of pediatric spinal canal sonography, especially in neonates and young infants for an occult tethered spinal cord. |
| SA3 |
Can We Piggyback an Anatomy Scan Onto the Nuchal Translucency Scan?
Ilan Timor, MD
Measurement of nuchal translucency (NT) as part of the 11- to 14-week early screening is becoming the standard of care. Since the development of new high-resolution ultrasound probes as well as transvaginal probes, we are able to detect normal anatomy as well as pathology at these gestational ages. Therefore, it is logical to extend the NT scan to include a first-trimester anatomy scan. A large number of anomalies can be detected at this early age, enabling the patient and the obstetrician to plan for appropriate management of the pregnancy. |
SA4 |
Cervical Sonography and Prematurity: A Gestational Age-Specific and Case-Based Approach SOLD OUT
Joseph Wax, MD
Following this session, participants will be able to describe the correct technique of transvaginal cervical sonography and use this measurement in second- and third-trimester pregnancies. |
SA5 |
Lung Ultrasonography in Critically Ill Patients SOLD OUT
Daniel Lichtenstein, MD
The purpose of this session is to make attendees familiar with lung ultrasonographic applications allowing diagnoses of pneumothorax, alveolar consolidation, and interstitial syndrome and their role in assessing critically ill patients. |
Saturday, March 15, 2008
12:30 PM-1:30 PM |
SP1 |
Diagnosis of Fetal Cardiac Anomalies SOLD OUT
Carol Benson, MD
After attending this session, participants will understand how to evaluate the fetal heart to assess for cardiac anomalies. They will be able to recognize the various ultrasound views that are used to assess fetal cardiac anatomy, will recognize the appearance of an abnormal fetal heart, and will be able to understand some of the more common cardiac anomalies that occur. They will also learn about some of the innovative treatments being performed on fetuses with congenital heart anomalies that improve the outcomes for those fetuses. |
| SP2 |
Update on Ultrasound-Guided Radio Frequency Ablation
John McGahan, MD
Following this session, participants will be able to perform routine radio frequency ablation of solid organs, understand methods of avoiding complications of radio frequency ablation, and understand techniques used to perform difficult radio frequency ablations. |
SP3 |
Genetic Sonography After First-Trimester Risk Assessment SOLD OUT
David Nyberg, MD
Following this session, participants will be able to correlate a second-trimester anatomic survey and "genetic sonogram" with first-trimester screening results and estimate an overall risk for fetal aneuploidy. First-trimester screening results consider maternal age, nuchal translucency measurement, gestational age, and biochemical values of pregnancyassociated plasma protein A and human chorionic gonadotropin. Participants will be able to weight individual sonographic markers of the secondtrimester genetic sonogram. |
SP4 |
Doppler Ultrasound Versus the Biophysical Profile in Timing the Delivery of the Preterm Growth-Restricted Fetus SOLD OUT
Anthony Odibo, MD
Following this session, participants will be able to understand the use of Doppler ultrasound versus the biophysical profile (BPP) in monitoring growthrestricted pregnancies, discuss the utility of Doppler ultrasound versus the BPP in timing the delivery of the preterm growth-restricted fetus, and evaluate the pros and cons of the concept of integrated fetal testing. |
| SP5 |
Ultrasound and Reproductive Medicine
Elizabeth Puscheck, MD, MS
After this session, participants will be able to discuss the role of ultrasound in the initial evaluation and treatment of patients with common reproductive endocrine and infertility problems. |
